
    
      Iron will be provided in an open label treatment to all enrolled subjects. Iron levels will
      be monitored in blood and doses adjusted with the target of getting the iron levels to or a
      little above 100 mcg/dl.

      The study will look to see if there is a decrease of FGF23 level. It will also look at how
      long does it take to decrease the level of FGF 23 and how long it takes for the serum and
      urine phosphate to normalize.
    
  